Alivus Life Sciences Ltd.
₹861.3
-7.1 (-0.8%)
ALIVUS Share Price
As on January 21, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 10,611 Cr
P/E Ratio21.73
Dividend Yield0.29 %
Trendline Performance
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open855.3
High866
NSE SymbolALIVUS
Close861.3
Low843.65
BSE Symbol543322
Previous Years High/Low
1 Year High1,251
3 Year High1,335.1
5 Year High1,335.1
1 Year Low836.95
3 Year Low370
5 Year Low370
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 873.44 | Bearish |
| 10-DMA | 883.52 | Bearish |
| 20-DMA | 895.09 | Bearish |
| 50-DMA | 897.16 | Bearish |
| 100-DMA | 916.09 | Bearish |
| 200-DMA | 973.79 | Bearish |
Historical Performance
1 Year
-25.1%
3 Years
115.1%
5 Years
N/A
10 Years
N/A
Shareholding Pattern
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:29.1
TTM:-23.3
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a moderate PE of 21.73, suggesting fair valuation relative to earnings.
- Over the last three years, the stock delivered a strong 3-year price CAGR of 29.3%, indicating sustained price appreciation.
- The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
- In the last financial year, the company reported an EBITDA of ₹7172 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹23869 million, indicating a large and established business.
Investment Calculator
Investment Amount:
₹Investment Amount: ₹ 1000000
Current Value: ₹ 767202.6
No. of Shares: 891 (Approx)
Performance:-23.3%
P/L: ₹-232797.4
NIFTY Performance: 8.6%
1 day Top Gainers
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
